Search research articles
Contact Us
Filters
Showing results (181-190 of 268) with videos related to
Page
of 27
Sort By:
Neuron
|
May 4, 2010
Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2
Brad E Pfeiffer, Tong Zang, Julia R Wilkerson, et al.
Mini Reviews in Medicinal Chemistry
|
March 23, 2004
Imatinib (STI571) resistance in chronic myelogenous leukemia: molecular basis of the underlying mechanisms and potential strategies for treatment
Sandra W Cowan-Jacob, Valerie Guez, Gabriele Fendrich, et al.
Breast Cancer Research : BCR
|
May 29, 2026
Kaiso modulates androgen receptor expression in triple-negative breast cancer
Stephanie Ali Fairbairn, Kyle Kim, Robert W Cowan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 5, 1999
Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene
Z Rahman, S J Gold, M N Potenza, et al.
The Journal of Biological Chemistry
|
March 4, 2005
Growth hormone receptor is a target for presenilin-dependent gamma-secretase cleavage
Jon W Cowan, Xiangdong Wang, Ran Guan, et al.
Innovations (Philadelphia, Pa.)
|
March 16, 2019
Early Discharge Does Not Increase Readmission Rates After Minimally Invasive Anatomic Lung Resection
Guillaume S Chevrollier, Amanda K Nemecz, Courtney Devin, et al.
Human Pathology
|
June 25, 2010
Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone
Isabella W Y Mak, Eric P Seidlitz, Robert W Cowan, et al.
Eneuro
|
February 13, 2025
Heroin Regulates the Voltage-Gated Sodium Channel Auxiliary Subunit, SCN1b, to Modulate Nucleus Accumbens Medium Spiny Neuron Intrinsic Excitability and Cue-Induced Heroin Seeking
Ethan M Anderson, Evgeny Tsvetkov, Daniel Wood, et al.
ACS Chemical Biology
|
July 10, 2015
Type II Inhibitors Targeting CDK2
Leila T Alexander, Henrik Möbitz, Peter Drueckes, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
December 14, 2006
Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia
Sandra W Cowan-Jacob, Gabriele Fendrich, Andreas Floersheimer, et al.
Page
of 27
Search research articles
Search
Showing results (181-190 of 268) with videos related to
Sort By:
Page
of 27
Neuron
|
May 4, 2010
Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2
Brad E Pfeiffer, Tong Zang, Julia R Wilkerson, et al.
Mini Reviews in Medicinal Chemistry
|
March 23, 2004
Imatinib (STI571) resistance in chronic myelogenous leukemia: molecular basis of the underlying mechanisms and potential strategies for treatment
Sandra W Cowan-Jacob, Valerie Guez, Gabriele Fendrich, et al.
Breast Cancer Research : BCR
|
May 29, 2026
Kaiso modulates androgen receptor expression in triple-negative breast cancer
Stephanie Ali Fairbairn, Kyle Kim, Robert W Cowan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 5, 1999
Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene
Z Rahman, S J Gold, M N Potenza, et al.
The Journal of Biological Chemistry
|
March 4, 2005
Growth hormone receptor is a target for presenilin-dependent gamma-secretase cleavage
Jon W Cowan, Xiangdong Wang, Ran Guan, et al.
Innovations (Philadelphia, Pa.)
|
March 16, 2019
Early Discharge Does Not Increase Readmission Rates After Minimally Invasive Anatomic Lung Resection
Guillaume S Chevrollier, Amanda K Nemecz, Courtney Devin, et al.
Human Pathology
|
June 25, 2010
Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone
Isabella W Y Mak, Eric P Seidlitz, Robert W Cowan, et al.
Eneuro
|
February 13, 2025
Heroin Regulates the Voltage-Gated Sodium Channel Auxiliary Subunit, SCN1b, to Modulate Nucleus Accumbens Medium Spiny Neuron Intrinsic Excitability and Cue-Induced Heroin Seeking
Ethan M Anderson, Evgeny Tsvetkov, Daniel Wood, et al.
ACS Chemical Biology
|
July 10, 2015
Type II Inhibitors Targeting CDK2
Leila T Alexander, Henrik Möbitz, Peter Drueckes, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
December 14, 2006
Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia
Sandra W Cowan-Jacob, Gabriele Fendrich, Andreas Floersheimer, et al.
Page
of 27